期刊文献+

扶正抗癌方诱导H1650细胞凋亡的分子机制 被引量:8

Molecular Mechanism of Fuzheng Kang'ai Decoction in Inducing Apoptosis of H1650 Cells
原文传递
导出
摘要 目的:观察扶正抗癌方对H1650细胞凋亡的影响,并探讨其诱导H1650细胞凋亡的分子机制。方法:以人肺腺癌细胞株H1650细胞为研究对象,用0.5,1.0,1.5,2.0,2.5,3.0 g·L^(-1)扶正抗癌方处理H1650细胞24,48,72 h,另设空白组,四氮唑蓝盐化合物(MTS)法检测细胞增殖;用0.5,1.0,1.5 g·L^(-1)扶正抗癌方处理H1650细胞24 h,另设空白组,Annexin VFITC/碘化丙啶(PI)流式细胞术检测细胞凋亡;用0.5,1.0,2.0 g·L^(-1)扶正抗癌方处理H1650细胞24 h,另设空白组,半胱氨酸蛋白酶-3/7(Caspase-3/7)活力检测试剂盒检测Caspase-3/7活力;蛋白免疫印迹法检测扶正抗癌方对pro Casapse-3,聚腺苷二磷酸-核糖聚合酶(PARP),Bcl-2相关X蛋白(Bax)表达。结果:与空白组比较,扶正抗癌方能明显抑制H1650细胞的增殖(P<0.05),且呈浓度和时间依赖性。与空白组比较,扶正抗癌方明显诱导H1650细胞的早期凋亡,增强Caspase-3/7的活力(P<0.05),且呈浓度依赖性。与空白组比较,扶正抗癌方明显下调pro Casapse-3和PARP的表达(P<0.05),呈浓度依赖性,明显上调Bax的表达(P<0.05),且呈时间依赖性。结论:扶正抗癌方可通过激活Caspase-3和Bax诱导H1650细胞的凋亡。 Objective: To observe the effects of Fuzheng Kang'ai (FZKA) decoction on apoptosis of H1650 cells and discuss its molecular mechanism in apoptosis of H1650 cells. Method: Human lung adenocarcinoma cells (H1650 cells) were used as the research objects and treated for 24, 48,72 h with 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 g·L-1FZKA decoction, and a blank group was set up, then cell proliferation was detected by 3- (4, 5-diethylthiazol-2-yl ) -5- ( 3-carboxymethoxyphenyl ) -2- ( 4-sulfophenyl ) -2 H-etrazolium, inner salt ( MTS ) assay. H1650 cells were treated for 24 h with 0.5, 1.0, 1.5 g·L-1 FZKA decoction and a blank group was set up, then cell apoptosis was detected by Annexin V-FITC/PI flow cytometry analysis. H1650 cells were treated for 24 h with 0.5, 1.0, 2.0 g·L-1 FZKA decoction and a blank group was set up, then vitality of Caspase-3/7 was detected by Caspase-3/7 vitality test kit. Simultaneously, effects of FZKA decoction on the expression levels of proCasapse- 3, PARP and Bax were detected by Western blot assay. Result : As compared with the blank group, proliferation of H1650 ceils was significantly inhibited by FZKA decoction in concentration-dependent and time-dependent manners (P 〈 0.05). As compared with the blank group, early apoptosis of H1650 cells was significantly induced and vitality of Caspase-3/7 was increased by FZKA decoction in a concentration-dependent manner (P 〈 O. 05). As compared with the blank group, the expression levels of proCasapse-3 and PARP were significantly reduced by FZKA decoction in a concentration-dependent manner (P 〈 0. 05) , and the expression of Bax was increased by FZKA decoction in a time-dependent manner (P 〈0. 05). Conclusion : Apoptosis is induced by FZKA decoction in way of activating Caspase-3 and Bax in H1650 ceils.
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2016年第14期106-110,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家自然科学基金项目(81273965 81503507) 广东省自然科学基金项目(2015A030310245) 广东省建设中医药强省科研项目(20141104)
关键词 扶正抗癌方 细胞凋亡 半胱氨酸蛋白酶-3/7 Bcl-2相关X蛋白 Fuzheng Kang'ai decoction apoptosis Caspase-3/7 Bax
  • 相关文献

参考文献18

  • 1Yang X B,Wu W Y,Long S Q, et al. Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study[ J]. Complement Ther Med,2014,22 (6) :1010-1018.
  • 2吴万垠,杨小兵,龙顺钦,邓宏,蔡姣芝,杨昌卫,河文峰,潘宗奇,周宇姝,欧阳育树,廖桂雅.扶正抗癌方联合吉非替尼治疗晚期非小细胞肺癌优势人群与非优势人群的比较[J].时珍国医国药,2013,24(9):2152-2154. 被引量:23
  • 3杨昌卫.扶正抗癌方联合吉非替尼治疗晚期非小细胞肺癌的临床研究[D].广州:广州中医药大学,2011.
  • 4杨小兵,吴万垠,龙顺钦,等.扶正抗癌方联合吉非替尼对H1650裸鼠移植瘤EGFR、AKT及ERK表达的影响[C].广州:第五届国际中医、中西医结合肿瘤学术交流大会暨第十四届全国中西医结合肿瘤学术大会,2014.
  • 5杨小兵,吴万垠,龙顺钦,等.扶正抗癌方联合吉非替尼对肺癌H1650细胞株裸鼠移植瘤的抑制作用[C].广州:第五届国际中医、中西医结合肿瘤学术交流大会暨第十四届全国中西医结合肿瘤学术大会,2014.
  • 6杨小兵,陈晓,吴万垠,等.扶正抗癌方联合吉非替尼对肺癌A549细胞的影响及机制研究[c].重庆:第一届青年中西医结合肿瘤学术论坛,2015.
  • 7Zheng F,Wu J J, Li X, et al. Chinese herbal medicine Fuzheng Kangai decoction inhibited lung cancer cell growth through AMPK a-mediated induction and interplay of IGFBP1 and FOXO3a [ J ]. Evid Based Complement Alternat Med, 2016: 5060757. doi: 10. 1155/2016/5060757.
  • 8Wong R S. Apoptosis in cancer: from pathogenesis to treatment[J]. J Exp Clin Cancer Res,2011,30(1): 1096-1104.
  • 9Tihon R,Paiva A A,Guan J Q, et al. A comprehensive platform for quality control of botanical drugs (Phytomics QC ): a case study of Huangqin Tang (HQT) and PHY906[J]. Chin Med,2010,5(1): 30-44.
  • 10林晓斐.《中国居民营养与慢性病状况报告(2015年)》发布[J].中医药管理杂志,2015,23(13):89-89. 被引量:103

二级参考文献42

  • 1D'Costa A M, Denning M F. A casppase-resistant mutant of PKC-deha protects keratinocytes friom UV-induced apoptosis[J]. Cell Death Differ, 2005, 12(3):224-232.
  • 2Logette E, Solary E, Corcos L. Ildentification of a funetional DNA binding site for the SREBP-1 etranseription factor in the first intron of the human caspase-2 gene [J]. Biochim Biophys Aceta, 2005,1738(1-3):1-5.
  • 3Lee S C, Chan J, Clement M V, et al. Functional proteomics of resveratrol-induced colon cancer cell apoptosis:caspase-6-mediated cleavage of laminA is a major signaling loop [J]. Proteomics, 2006, 6(8):2386-2394.
  • 4Shakibaei M, John T, Seifarth C, et al. Resveratrol inhibitsIL-1beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro [J]. Ann NY Acad Sci, 2007, 1095: 554-563.
  • 5Stepien A, lzdebska M, Grzanka A. The types of cell death [J]. Postepy Hig Med Dosw(Online),2007,61:420-428.
  • 6Joseph E K, LevineJ D. Caspase signalling in neuropathic and inflammatory pain in the rat [J]. Eur J Neurosei, 2004, 20(11): 2896-2902.
  • 7Visconti R, DAdamio L. Functional cloning of genes regulating apoptosis in neuronal cells [J]. Methods Mol Biol, 2007, 399: 125-131.
  • 8Kuribayashi K, Mayes P A, El-Deiry W S. What are caspases 3 and 7 doing upstream of the mitochondria [J]. Cancer Biol Ther, 2006, 5(7):763-765.
  • 9Lockshin R A. Programmed cell death: bistory and future of a concept[J]. J Soc Biol,2005,199(3): 169-173.
  • 10Thornberry N A, Lazebnik Y L.Caspase:Enemics within[J]. Science,1998, 281:1312-1316.

共引文献346

同被引文献41

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部